Cvs Group Plc Stock Revenue

4C9 Stock  EUR 10.60  0.20  1.85%   
CVS Group plc fundamentals help investors to digest information that contributes to CVS Group's financial success or failures. It also enables traders to predict the movement of CVS Stock. The fundamental analysis module provides a way to measure CVS Group's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CVS Group stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

CVS Group plc Company Revenue Analysis

CVS Group's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Revenue

 = 

Money Received

-

Discounts and Returns

More About Revenue | All Equity Analysis

Current CVS Group Revenue

    
  554.2 M  
Most of CVS Group's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CVS Group plc is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition
Based on the latest financial disclosure, CVS Group plc reported 554.2 M of revenue. This is 92.23% lower than that of the sector and 67.04% lower than that of the Revenue industry. The revenue for all Germany stocks is 94.13% higher than that of the company.

CVS Revenue Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CVS Group's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CVS Group could also be used in its relative valuation, which is a method of valuing CVS Group by comparing valuation metrics of similar companies.
CVS Group is currently under evaluation in revenue category among its peers.

CVS Fundamentals

About CVS Group Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze CVS Group plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CVS Group using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CVS Group plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in CVS Stock

CVS Group financial ratios help investors to determine whether CVS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CVS with respect to the benefits of owning CVS Group security.